Stockholders' Equity - Summary of Non-Vested Options (Detail) |
3 Months Ended |
|---|---|
|
Feb. 28, 2021
$ / shares
shares
| |
| Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] | |
| Non-vested at November 30, 2020, Shares | shares | 93,380 |
| Vested, Shares | shares | (23,720) |
| Non-vested at February 28, 2021, Shares | shares | 69,660 |
| Non-vested at November 30, 2020, Weighted Average Grant-Date Fair Value | $ / shares | $ 4.65 |
| Vested, Weighted Average Grant-Date Fair Value | $ / shares | 4.99 |
| Non-vested at February 28, 2021, Weighted Average Grant-Date Fair Value | $ / shares | $ 4.53 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-vested options outstanding. No definition available.
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options outstanding. No definition available.
|
| X | ||||||||||
- Definition Number of options vested. No definition available.
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of options vested. No definition available.
|